Jpmorgan Healthcare Leade... (JDOC)
NasdaqGM: JDOC
· Echtzeitkurs · USD
62.34
+2.21 (3.68%)
Zum Schluss: Aug 12, 2026, 9:37 AM
62.34
+0.76%
Nachbörslich: 4:10 PM
Jpmorgan Healthcare Leaders ETF (JDOC) ETF Price, Holdings & Analysis
3.68% (1D)
| Geld | 43.72 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 9.07 Mio |
| NAV | 62.54 |
| Beta | k.A. |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | 29.40 |
| Ausstehende Anteile | k.A. |
| Auflagedatum | Nov 1, 2023 |
| Brief | 77.81 |
| Volumen | 876 |
| Ø Vol. (20D) | 427 |
| Eröffnung | 61.80 |
| Vortagesschluss | 60.13 |
| Tagesspanne | 61.75 - 62.34 |
| 52-Wk Range | 49.91 - 62.45 |
| Positionen | k.A. |
| Kostenquote | 0.65% |
Über JDOC
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Anlageklasse Equity
Tickersymbol JDOC
Auflagedatum Nov 1, 2023
Anbieter Jpmorgan
Website Fonds-Homepage
Börse NasdaqGM
Top 10 Positionen 48.10% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Abbvie Inc | ABBV | 7.85% |
| Eli Lilly And Co | LLY | 7.76% |
| Unitedhealth Group I... | UNH | 5.85% |
| Merck & Co Inc | MRK | 4.82% |
| Johnson & Johnson | JNJ | 4.82% |
| Astrazeneca PLC | AZN.L | 3.76% |
| Thermo Fisher Scient... | TMO | 3.73% |
| Bristol-myers Squibb... | BMY | 3.57% |
| Abbott Laboratories | ABT | 3.11% |
| Cvs Health Corp | CVS | 2.83% |
Dividenden Dividendenrendite 0.82%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Dec 16, 2025 | $0.5120 | k.A. |
| Dec 24, 2024 | $0.3280 | k.A. |
| Dec 16, 2024 | $2.4890 | k.A. |
| Dec 19, 2023 | $0.0800 | k.A. |